Avacta
Avacta is a biotechnology company specializing in the development of innovative diagnostics and therapeutic solutions. Leveraging its proprietary Affimer® platform, Avacta focuses on creating next-generation biotherapeutics and high-performance diagnostic reagents to address unmet medical needs. The company’s expertise spans drug development, immunodiagnostics, and precision medicine, supporting advancements in healthcare and research. Avacta collaborates with pharmaceutical and diagnostic partners to accelerate the delivery of novel treatments and reliable diagnostic tools. Committed to scientific excellence and innovation, Avacta aims to improve patient outcomes and contribute to the global life sciences sector through its cutting-edge technologies and solutions.
